Objective To investigate the impacts of the combined therapy of ganoderma lucidum polysaccharide(GLP)and decorin(DCN)gene on immunological function and its anti-tumor effect in mice bearing S180.Methods S180 solid transplanted carcinoma models were established among 32 mice,which were randomized into normal saline group(NS group),GLP group,DCN group and DCN+GLP group.The volume of tumors was measured and MTT method was adopted to test the transformation of T lymphocytes.ELISA was used to test the changes in serum VEGF.Flow cytometry was used to test the percentage of CD +4 CD+25 regulatory T cells in CD +4 T cells.Results It was found in every treatment group that the growth of tumor was slow down averagely in volume,the proliferative rate of lymphocytes was increased significantly(P0.05),VEGF expression was downgraded apparently and the percentage of CD +4 CD+25 regulatory T cells in CD +4 T cells was reduced obviously.Conclusion The combination of GLP and DCN gene can improve significantly the activity of immune system of tumor bearing mice and suppress tumor growth.